Dr. Thomas Ecker
ActiveSummary
Dr. Thomas Ecker has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €50,646 and a net result of -€30,363. Equity is shrinking by ~9.1% per year across the filed fiscal years. Its solvency ranks better than 67% of 20,374 sector peers (NACE 86, fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 28 days late
2025
30-09
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 61 days late
2024
31-12
Financial
Weakest financial yearnet -€33,674
Net result drops to -€33,674, the lowest in the series; recovery starts the following year.
30-09
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 61 days late
2023
31-12
Financial
Liquidity quadruplescurrent ratio 21.30
Current ratio from 5.57 to 21.30; short-term debt falls from €20,649 to €4,775.
31-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 31 days late
2022
31-12
Financial
Highest result since 2021net €64,484 ▲50.7%
Operating result €82,914, net result €64,484, both a record.
31-12
Financial
Liquidity triplescurrent ratio 5.57
Current ratio from 1.98 to 5.57; short-term debt falls from €39,353 to €20,649.
31-12
Financial
Equity above €100,000Eq €112,064 ▲136%
2 profitable years in a row build equity to €112,064.
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.